Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
8-week randomized double-blind placebo-controlled trial of levetiracetam for neuroleptic-induced tardive dyskinesia
2004-001302-27Phase 2Completed
- Sponsor
- UCB
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in tardive dyskinesia (TD), akathisia and Extrapyramidal symptoms (EPS) comparing Levetiracetam arm with Placebo arm (2 arms). Primary endpoint: Primary efficacy on tardive dyskinesia. Started Mar 2005; status: completed.
02
Drugs
levetiracetam
03
Conditions
tardive dyskinesia (TD)akathisiaExtrapyramidal symptoms (EPS)
Beyond the preview
Go deeper on 2004-001302-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001302-27.